These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17317514)

  • 21. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biomarkers of heart failure.
    Apple FS; Wu AH; Jaffe AS; Panteghini M; Christenson RH; ;
    Clin Biochem; 2008 Mar; 41(4-5):222-6. PubMed ID: 18035345
    [No Abstract]   [Full Text] [Related]  

  • 22. Improving risk stratification for heart failure. A role for serial testing of B-type natriuretic peptides?
    Daly MG; Frampton CM; Troughton RW
    J Am Coll Cardiol; 2010 Feb; 55(5):451-3. PubMed ID: 20117458
    [No Abstract]   [Full Text] [Related]  

  • 23. Natriuretic peptide tests in suspected acute heart failure.
    Rutten FH; Hoes AW
    BMJ; 2015 Mar; 350():h1164. PubMed ID: 25740798
    [No Abstract]   [Full Text] [Related]  

  • 24. [BNP as a biomarker of hypertensive complications].
    Shoji M; Yasujima M
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():133-6. PubMed ID: 16983764
    [No Abstract]   [Full Text] [Related]  

  • 25. Natriuretic peptide testing in primary care.
    Murphy JJ; Fuat A
    Circulation; 2006 Mar; 113(9):f35-6. PubMed ID: 16523535
    [No Abstract]   [Full Text] [Related]  

  • 26. B-type natriuretic peptide-a CPK for heart-failure and beyond (ischemia)?
    Arora V; Bhandari S
    Indian Heart J; 2006; 58(2):90-2. PubMed ID: 18989049
    [No Abstract]   [Full Text] [Related]  

  • 27. [NT-proBNP in practice: from chemistry to medicine].
    Jourdain P; Lefèvre G; Oddoze C; Sapin V; Dievart F; Jondeau G; Meune C; Galinier M
    Ann Cardiol Angeiol (Paris); 2009 Jun; 58(3):165-79. PubMed ID: 19457468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The coming of age of natriuretic peptides: the emperor does have clothes!
    Maisel A
    J Am Coll Cardiol; 2006 Jan; 47(1):61-4. PubMed ID: 16386665
    [No Abstract]   [Full Text] [Related]  

  • 29. Evolution of amino-terminal pro-B type natriuretic peptide testing in heart failure.
    Januzzi JL; Bayes-Genis A
    Drug News Perspect; 2009 Jun; 22(5):267-73. PubMed ID: 19609464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing prognosis in heart failure: you can see a lot if you look, but more if you look again.
    Squire I
    Eur Heart J; 2008 Apr; 29(8):959-60. PubMed ID: 18349028
    [No Abstract]   [Full Text] [Related]  

  • 31. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine practice guidelines: Analytical issues for biomarkers of heart failure.
    Apple FS; Wu AH; Jaffe AS; Panteghini M; Christenson RH; Cannon CP; Francis G; Jesse RL; Morrow DA; Newby LK; Storrow AB; Tang WH; Pagani F; Tate J; Ordonez-Llanos J; Mair J; ;
    Circulation; 2007 Jul; 116(5):e95-8. PubMed ID: 17630411
    [No Abstract]   [Full Text] [Related]  

  • 32. Brain natriuretic peptide in heart failure.
    Aronow WS
    J Am Geriatr Soc; 2006 Feb; 54(2):368-9; author reply 369. PubMed ID: 16460396
    [No Abstract]   [Full Text] [Related]  

  • 33. N-terminal pro-brain natriuretic peptide testing in the emergency department: beneficial effects on hospitalization, costs, and outcome.
    Rutten JH; Steyerberg EW; Boomsma F; van Saase JL; Deckers JW; Hoogsteden HC; Lindemans J; van den Meiracker AH
    Am Heart J; 2008 Jul; 156(1):71-7. PubMed ID: 18585499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating natriuretic peptide levels in acute heart failure.
    Maisel A
    Rev Cardiovasc Med; 2007; 8 Suppl 5():S13-21. PubMed ID: 18192949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Tailored drug therapy in heart failure--a future vision. Biological markers can support individually directed treatment].
    Dahlström U
    Lakartidningen; 2009 Oct 14-20; 106(42):2674-5. PubMed ID: 19967945
    [No Abstract]   [Full Text] [Related]  

  • 36. Advances in congestive heart failure management in the intensive care unit: B-type natriuretic peptides in evaluation of acute heart failure.
    Omland T
    Crit Care Med; 2008 Jan; 36(1 Suppl):S17-27. PubMed ID: 18158473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in heart failure: natriuretic peptide testing.
    Rehman SU; Januzzi JL
    Panminerva Med; 2008 Jun; 50(2):139-51. PubMed ID: 18607337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Safe diagnosis in acute phase with T-proBNP. Heart failure and acute coronary syndrome can be identified very early].
    Javadzadeh J; Collén AC; Manhem K; Swedberg K
    Lakartidningen; 2008 Feb 27-Mar 4; 105(9):616-9. PubMed ID: 18376704
    [No Abstract]   [Full Text] [Related]  

  • 39. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.
    Felker GM; Hasselblad V; Hernandez AF; O'Connor CM
    Am Heart J; 2009 Sep; 158(3):422-30. PubMed ID: 19699866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natriuretic peptide testing for heart failure therapy guidance in the inpatient and outpatient setting.
    Green SM; Green JA; Januzzi JL
    Am J Ther; 2009; 16(2):171-7. PubMed ID: 19300043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.